Aralez

Discussion in 'Biotech Startups' started by anonymous, Jul 17, 2016 at 8:29 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    No.
     

  2. anonymous

    anonymous Guest

    AA doesn't need the sales forces to sell.
     
  3. anonymous

    anonymous Guest

    Is this company worth an interview? Is Yosprala a dude or is it getting any traction?
     
  4. anonymous

    anonymous Guest

    It's a DUD! It's 2 fucking generics! Why the fukk would you pay for Yosprala when aspirin and prilosec are available OTC for pennies??!! My docs are laughing, this is embarrassing!
     
  5. anonymous

    anonymous Guest

    Vorapaxar sounds like a nightmare.
     
  6. anonymous

    anonymous Guest

    Answer to your questions is Fuck NO!
     
  7. anonymous

    anonymous Guest

    Any word on severance?
     
  8. anonymous

    anonymous Guest

    Guarantee they will force people out before they pay severance.
     
  9. anonymous

    anonymous Guest

    This is exactly what my docs are saying.
     
  10. anonymous

    anonymous Guest

    This.
     
  11. anonymous

    anonymous Guest

    You have no fucking clue what the nightmare will be like when you sell Vorapaxar. Expensive as shit, no coverage, very small incremental benefit, and too much bleeding! Its a piece of fuck drug. It's the reason we all lost our jobs at Merck because we couldn't sell hardly any of it for 2 years. No indication for ACS, 2 generics ahead of it before you're allowed to even think about using it, and weak outcome trial data.

    You guys were fucking stupid to buy it for what you did. I think we sold 1.75 million in 2 years? And you fucknuts bought it for what, $22 million? Real fucking Einsteins you must have running the company.

    Good luck you fucks...signed,

    Fucktard
     
  12. anonymous

    anonymous Guest

    Junk.
     
  13. anonymous

    anonymous Guest

    Maybe we can sell this Merck reject off label. Sounds like another POS drug.
     
  14. anonymous

    anonymous Guest

    It is!
     
  15. anonymous

    anonymous Guest

    No one is getting laid off or forced out that's silly talk
     
  16. anonymous

    anonymous Guest

    OK. Wait and see!
     
  17. anonymous

    anonymous Guest

     
  18. anonymous

    anonymous Guest

    I'd say we'll know by end of q2. Let's just hope the company hit its numbers for 2016!
     
  19. anonymous

    anonymous Guest

    They'll sell off the products before they completely tank... You're high if you think you have a long-term career here.
     
  20. anonymous

    anonymous Guest

    No place for a career.